SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-002393
Filing Date
2021-02-16
Accepted
2021-02-16 08:35:45
Documents
16
Period of Report
2021-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_021121.htm   iXBRL 8-K 30238
2 UNDERWRITING AGREEMENT ex1-1.htm EX-1.1 220070
3 OPINION OF GREENBERG TRAURIG, LLP ex5-1.htm EX-5.1 21353
7 GRAPHIC txmd001.jpg GRAPHIC 4959
8 GRAPHIC txmd002.jpg GRAPHIC 953
  Complete submission text file 0001387131-21-002393.txt   511901

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20210211.xsd EX-101.SCH 3208
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20210211_lab.xml EX-101.LAB 35274
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20210211_pre.xml EX-101.PRE 23161
9 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_021121_htm.xml XML 3767
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 21632869
SIC: 2834 Pharmaceutical Preparations